Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EDAP EDAP TMS	$1.70 -0.1%	$1.83	$1.26 ▼ $5.46	$63.49M	0.01	98,344 shs	1,677 shs
HYPR Hyperfine	$0.69 -0.8%	$0.70	$0.53 ▼ $1.90	$54M	0.95	901,800 shs	225,311 shs
IRIX IRIDEX	$0.93 -4.4%	$1.05	$0.78 ▼ $2.41	$15.66M	0.61	50,764 shs	57,297 shs
TELA TELA Bio	$1.65 -1.2%	$1.29	$0.86 ▼ $5.56	$65.27M	0.78	231,523 shs	46,242 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EDAP EDAP TMS	-0.12%	-0.70%	-2.41%	-22.47%	-67.69%
HYPR Hyperfine	-0.77%	-3.91%	+17.59%	-15.39%	-16.41%
IRIX IRIDEX	-4.44%	-0.76%	-8.53%	-5.76%	-52.76%
TELA TELA Bio	-1.20%	-2.94%	+18.71%	+12.24%	-67.52%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EDAP EDAP TMS	1.8399 of 5 stars	3.2	3.0	0.6	1.7	0.6
HYPR Hyperfine	2.2478 of 5 stars	3.3	3.0	0.6	2.5	0.6
IRIX IRIDEX	0.3161 of 5 stars	0.0	3.0	0.9	1.7	0.0
TELA TELA Bio	2.1528 of 5 stars	3.4	3.0	1.0	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EDAP EDAP TMS	2.33	Hold	$8.50	400.59% Upside
HYPR Hyperfine	2.67	Moderate Buy	$1.06	52.78% Upside
IRIX IRIDEX	0.00	N/A	N/A	N/A
TELA TELA Bio	2.75	Moderate Buy	$7.25	339.39% Upside

Current Analyst Ratings Breakdown

Latest IRIX, EDAP, TELA, and HYPR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/3/2025	HYPR Hyperfine	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/15/2025	EDAP EDAP TMS	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
5/15/2025	HYPR Hyperfine	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$1.20 ➝ $1.00
5/14/2025	HYPR Hyperfine	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$1.29 ➝ $0.68
4/4/2025	EDAP EDAP TMS	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$8.00 ➝ $2.00
3/28/2025	EDAP EDAP TMS	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$5.00 ➝ $4.50
3/28/2025	EDAP EDAP TMS	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$19.00 ➝ $19.00
3/24/2025	HYPR Hyperfine	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$1.50
3/21/2025	TELA TELA Bio	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$12.00 ➝ $7.00
3/21/2025	TELA TELA Bio	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$5.00 ➝ $2.00

(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EDAP EDAP TMS	$69.18M	0.92	N/A	N/A	$1.18 per share	1.44
HYPR Hyperfine	$12.89M	4.19	N/A	N/A	$0.67 per share	1.04
IRIX IRIDEX	$48.67M	0.32	N/A	N/A	$0.13 per share	7.18
TELA TELA Bio	$69.30M	0.94	N/A	N/A	$0.72 per share	2.29

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EDAP EDAP TMS	-$20.58M	-$0.62	N/A	N/A	N/A	-34.45%	-51.42%	-26.43%	8/27/2025 (Estimated)
HYPR Hyperfine	-$40.72M	-$0.54	N/A	N/A	N/A	-343.42%	-74.19%	-62.40%	8/6/2025 (Estimated)
IRIX IRIDEX	-$8.91M	-$0.43	N/A	∞	N/A	-14.61%	-290.57%	-22.86%	8/6/2025 (Estimated)
TELA TELA Bio	-$37.84M	-$1.41	N/A	N/A	N/A	-61.00%	-402.45%	-62.73%	8/11/2025 (Estimated)

Latest IRIX, EDAP, TELA, and HYPR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/15/2025	Q1 2025	EDAP EDAP TMS	-$0.16	-$0.20	-$0.04	-$0.20	$16.56 million	$16.37 million
5/13/2025	Q1 2025	HYPR Hyperfine	-$0.12	-$0.12	N/A	-$0.12	$2.82 million	$2.14 million
5/13/2025	Q1 2025	IRIX IRIDEX	-$0.10	-$0.10	N/A	-$0.10	$12.10 million	$11.90 million
5/8/2025	Q1 2025	TELA TELA Bio	-$0.21	-$0.25	-$0.04	-$0.25	$17.35 million	$18.52 million
3/27/2025	Q4 2024	EDAP EDAP TMS	-$0.11	-$0.05	+$0.06	-$0.05	$20.83 million	$22.69 million
3/27/2025	Q4 2024	IRIX IRIDEX	-$0.05	-$0.05	N/A	-$0.05	$12.80 million	$12.70 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EDAP EDAP TMS	N/A	N/A	N/A	N/A	N/A
HYPR Hyperfine	N/A	N/A	N/A	N/A	N/A
IRIX IRIDEX	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EDAP EDAP TMS	0.10	1.74	1.21
HYPR Hyperfine	N/A	6.07	5.48
IRIX IRIDEX	4.28	1.95	1.27
TELA TELA Bio	2.28	4.22	3.40

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EDAP EDAP TMS	62.74%
HYPR Hyperfine	15.03%
IRIX IRIDEX	20.10%
TELA TELA Bio	94.35%

Insider Ownership

Company	Insider Ownership
EDAP EDAP TMS	0.23%
HYPR Hyperfine	30.98%
IRIX IRIDEX	7.40%
TELA TELA Bio	4.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EDAP EDAP TMS	230	37.39 million	37.31 million	Optionable
HYPR Hyperfine	190	77.83 million	53.72 million	Optionable
IRIX IRIDEX	120	16.79 million	15.55 million	Optionable
TELA TELA Bio	120	39.56 million	37.70 million	Optionable

IRIX, EDAP, TELA, and HYPR Headlines

Recent News About These Companies

TELA Bio (NASDAQ:TELA) Cut to Sell at Wall Street Zen

June 14, 2025 | americanbankingnews.com

Wall Street Zen Downgrades TELA Bio (NASDAQ:TELA) to Sell

June 14, 2025 | marketbeat.com

TELA Bio Welcomes Jim Hagen with Strategic Equity Grant

June 9, 2025 | msn.com

TELA Bio, Inc.: TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 7, 2025 | finanznachrichten.de

TELA Bio (NASDAQ:TELA) Stock Rating Upgraded by Wall Street Zen

June 7, 2025 | marketbeat.com

TELA Bio, Inc. Grants Inducement Equity Awards to New Senior Vice President Jim Hagen

June 6, 2025 | quiverquant.com

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 6, 2025 | globenewswire.com

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

June 5, 2025 | tmcnet.com

TELA Bio, Inc. (NASDAQ:TELA) Short Interest Down 13.6% in May

June 4, 2025 | marketbeat.com

TELA Bio Announces European Commercial Launch of OviTexÂ® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

June 3, 2025 | globenewswire.com

TELA Bio Names Jeffrey Blizard as President to Drive Strategic Growth

June 3, 2025 | msn.com

TELA Bio Appoints Jeffrey Blizard as President to Drive Growth and Innovation

June 2, 2025 | quiverquant.com

TELA Bio Appoints Jeffrey Blizard as President

June 2, 2025 | globenewswire.com

TELA Bio to Present at the 2025 Jefferies Global Healthcare Conference

May 25, 2025 | msn.com

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

May 22, 2025 | globenewswire.com

Piper Sandler Sticks to Their Hold Rating for TELA Bio (TELA)

May 22, 2025 | theglobeandmail.com

TELA Bio Announces Inducement Grants to New Hires with 4-Year Vesting Plan

May 12, 2025 | msn.com

TELA Bio Reports Q1 2025 Growth and Product Expansion

May 12, 2025 | msn.com

TELA Bio, Inc. (TELA) Q1 2025 Earnings Call Transcript

May 11, 2025 | seekingalpha.com

Earnings call transcript: Tela Bio Q1 2025 revenue miss, stock rises 9%

May 10, 2025 | uk.investing.com

TELA Bio Reports First Quarter 2025 Financial Results

May 10, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX, EDAP, TELA, and HYPR Company Descriptions

EDAP TMS NASDAQ:EDAP

$1.69 -0.01 (-0.59%)

As of 06/20/2025 04:00 PM Eastern

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

Hyperfine NASDAQ:HYPR

$0.69 -0.01 (-0.77%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$0.70 +0.01 (+0.89%)

As of 06/20/2025 07:59 PM Eastern

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

IRIDEX NASDAQ:IRIX

$0.93 -0.04 (-4.44%)

As of 06/20/2025 04:00 PM Eastern

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

TELA Bio NASDAQ:TELA

$1.65 -0.02 (-1.20%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$1.64 -0.01 (-0.61%)

As of 06/20/2025 04:04 PM Eastern

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time